The New York Times reports:
A key advisory committee to the Food and Drug Administration voted on Thursday to recommend a booster shot of the Moderna coronavirus vaccine for many of the vaccine’s recipients, at least six months after a second dose.
The panel endorsed a half-dose as a third injection for people 65 and older as well as younger adults at high risk because of their medical conditions or jobs, the same groups of people who became eligible for a Pfizer-BioNTech booster last month.
Johnson & Johnson has asked the Food and Drug Administration to issue emergency use authorization for a booster for recipients of their vaccines, and the panel will vote Friday on the company’s request.
Read the full article.
Breaking News: An FDA advisory panel voted to recommend a booster of the Moderna vaccine for those 65 and older as well as younger adults at high risk. https://t.co/uPsBxPuEXz
— The New York Times (@nytimes) October 14, 2021